Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Recap: Profound Medical Q2 Earnings

Profound Medical (NASDAQ:PROF) reported its Q2 earnings results on Thursday, August 4, 2022 at 04:00 PM. Here's what investors need to know about the announcement.
byBenzinga Insights
August 4, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Profound Medical (NASDAQ:PROF) reported its Q2 earnings results on Thursday, August 4, 2022 at 04:00 PM.

Here’s what investors need to know about the announcement.

Earnings

Profound Medical beat estimated earnings by 170.0%, reporting an EPS of $0.28 versus an estimate of $-0.4.

Revenue was down $602 thousand from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.03 which was followed by a 5.02% increase in the share price the next day.

To track all earnings releases for Profound Medical visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Lattice Semiconductor Reports Q1 Results, Guides Q2 Revenue Below Estimates

By Erica Kollmann
April 29, 4:29 PM
Lattice Semiconductor reported quarterly earnings of 29 cents per share which beat the analyst consensus estimate of 28 cents and is a 43.14% decrease from earnings of 51 cents per share from the same period last year. Quarterly sales clocked in at $140.815 million, beating the analyst consensus estimate of $140.138 million by 0.48% and representing a 23.6% decrease from sales of $184.31 million from the same period last year.

LSCC